Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 1Inflammation 1Fatigue 1Colorectal Neoplasms 1Cognitive Dysfunction 1Behavior 1

Interventions

Exercise 5Vitamin D 2Tea 2Sufentanil 2Spironolactone 2Probiotics 2Oxycodone 2Omeprazole 2Morphine 2Metformin 2Etanercept 2Colchicine 2Ascorbic Acid 2ziprasidone 1soybean oil, phospholipid emulsion 1salicylsalicylic acid 1ginger extract 1falcarinol 1falcarindiol 1epigallocatechin gallate 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Sulindac 1Sodium Salicylate 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Inflammation × Riluzole × Clear all
NCT02796755 2021-04-14

Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

Emory University

Phase 4 Completed
30 enrolled 10 charts

Behavior, Fatigue, Inflammation, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡